JP2025094953A5 - - Google Patents
Info
- Publication number
- JP2025094953A5 JP2025094953A5 JP2025036781A JP2025036781A JP2025094953A5 JP 2025094953 A5 JP2025094953 A5 JP 2025094953A5 JP 2025036781 A JP2025036781 A JP 2025036781A JP 2025036781 A JP2025036781 A JP 2025036781A JP 2025094953 A5 JP2025094953 A5 JP 2025094953A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962902156P | 2019-09-18 | 2019-09-18 | |
| US62/902,156 | 2019-09-18 | ||
| PCT/US2020/051430 WO2021055705A1 (en) | 2019-09-18 | 2020-09-18 | Biaminoquinolines and nanoformulations for cancer treatment |
| JP2022517438A JP7652434B2 (ja) | 2019-09-18 | 2020-09-18 | がん治療のためのビアミノキノリンとナノ製剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517438A Division JP7652434B2 (ja) | 2019-09-18 | 2020-09-18 | がん治療のためのビアミノキノリンとナノ製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025094953A JP2025094953A (ja) | 2025-06-25 |
| JP2025094953A5 true JP2025094953A5 (enExample) | 2025-11-06 |
Family
ID=74884705
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517438A Active JP7652434B2 (ja) | 2019-09-18 | 2020-09-18 | がん治療のためのビアミノキノリンとナノ製剤 |
| JP2025036781A Pending JP2025094953A (ja) | 2019-09-18 | 2025-03-07 | がん治療のためのビアミノキノリンとナノ製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517438A Active JP7652434B2 (ja) | 2019-09-18 | 2020-09-18 | がん治療のためのビアミノキノリンとナノ製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230348419A1 (enExample) |
| EP (1) | EP4031543A4 (enExample) |
| JP (2) | JP7652434B2 (enExample) |
| CN (2) | CN115023418B (enExample) |
| CA (1) | CA3154678A1 (enExample) |
| WO (1) | WO2021055705A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020012066A (es) | 2018-05-14 | 2021-04-28 | Nuvation Bio Inc | Compuestos anticancerígenos dirigidos a los receptores hormonales nucleares. |
| MX2021013774A (es) | 2019-05-14 | 2021-12-10 | Nuvation Bio Inc | Compuestos anticancerigenos dirigidos a los receptores hormonales nucleares. |
| TW202131930A (zh) | 2019-11-13 | 2021-09-01 | 美商諾維雪碧歐公司 | 抗癌核荷爾蒙受體標靶化合物 |
| IL306010A (en) | 2021-03-23 | 2023-11-01 | Nuvation Bio Inc | Anticancer compounds against the nuclear hormone receptor |
| AU2022269568A1 (en) | 2021-05-03 | 2023-11-16 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| CN114948938B (zh) * | 2022-02-22 | 2023-08-11 | 江苏省中医院 | 白术内酯i在制备预防和/或治疗宫颈癌的药物中的用途 |
| CN114948901B (zh) * | 2022-05-06 | 2023-04-21 | 郑州大学第一附属医院 | 一种协同治疗乳腺癌的依西美坦纳米粒、制剂及其制备方法 |
| CN116059172B (zh) * | 2023-02-01 | 2025-05-13 | 中山大学附属第八医院（深圳福田） | 一种纳米递药系统及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7183413B2 (en) * | 2003-04-11 | 2007-02-27 | Taigen Biotechnology | Aminoquinoline compounds |
| US20130011448A1 (en) * | 2010-03-16 | 2013-01-10 | Ge Healthcare Bio-Sciences Ab | System for improved delivery of gene modulating compounds |
| WO2012149186A2 (en) * | 2011-04-29 | 2012-11-01 | The Trustees Of The University Of Pennsylvania | Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| WO2015068142A2 (en) * | 2013-11-11 | 2015-05-14 | Cellworks Group, Inc. | Compositions, process of preparation of said compositions, uses and method of management of myeloproliferative disorder |
| US10221140B2 (en) * | 2014-08-08 | 2019-03-05 | The Trustees Of The University Of Pennsylvania | Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy |
| US10774047B2 (en) * | 2015-04-17 | 2020-09-15 | The Trustees Of The University Of Pennsylvania | Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy |
| WO2016196393A2 (en) * | 2015-05-29 | 2016-12-08 | Presage Biosciences, Inc. | Autophagy-inhibiting compounds and uses thereof |
| US20180280372A1 (en) * | 2016-11-22 | 2018-10-04 | Washington University | Compositions and methods for inhibiting autophagy and contraception |
-
2020
- 2020-09-18 US US17/761,162 patent/US20230348419A1/en active Pending
- 2020-09-18 CN CN202080080553.6A patent/CN115023418B/zh active Active
- 2020-09-18 JP JP2022517438A patent/JP7652434B2/ja active Active
- 2020-09-18 CA CA3154678A patent/CA3154678A1/en active Pending
- 2020-09-18 CN CN202411558409.5A patent/CN119591543A/zh active Pending
- 2020-09-18 EP EP20865741.1A patent/EP4031543A4/en active Pending
- 2020-09-18 WO PCT/US2020/051430 patent/WO2021055705A1/en not_active Ceased
-
2025
- 2025-03-07 JP JP2025036781A patent/JP2025094953A/ja active Pending